T38.3X2 Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, intentional self-harm

Name of the Condition

• Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, intentional self-harm

Summary

This condition involves intentional self-harm through poisoning by insulin or oral hypoglycemic (antidiabetic) drugs. It includes scenarios where these agents are used to cause harm, leading to adverse metabolic effects or overdose. The code applies to cases where self-inflicted exposure results in clinical toxicity or harm.

Causes

The causes are intentional self-harm, such as deliberate overdose or misuse of insulin or oral hypoglycemics. This may involve taking excessive doses, incorrect administration, or combining these drugs with other substances to induce harm. The intent is a key factor distinguishing this from accidental or therapeutic-related exposures.

Risk Factors

• History of self-harm or suicidal behavior
• Access to insulin or oral hypoglycemic medications
• Underlying psychiatric conditions (e.g., depression, anxiety)
• Social or environmental stressors
• Prior substance use or misuse
• Lack of supervision or support systems

Symptoms

Symptoms reflect hypoglycemia or related metabolic disturbances, including confusion, dizziness, sweating, tachycardia, tremors, or loss of consciousness. Severe cases may involve seizures, coma, or multi-organ dysfunction. Onset and severity depend on the agent, dose, and individual factors.

Diagnosis

Diagnosis requires a thorough clinical evaluation, including patient history (especially regarding intent), physical examination, and laboratory tests (e.g., blood glucose, drug levels). Documentation of self-harm intent is critical. Additional assessments may include psychiatric evaluation to address underlying conditions.

Treatment Options

Treatment focuses on stabilizing the patient, reversing hypoglycemia (e.g., glucose administration), and managing complications. Supportive care, such as monitoring vital signs and organ function, is essential. Psychiatric intervention and safety planning are necessary to address the self-harm behavior.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying health. Early intervention improves outcomes. Follow-up includes monitoring for recurrence, psychiatric care, and coordination with mental health services to reduce future risk.

Complications

Complications may include severe hypoglycemia, seizures, coma, organ damage (e.g., renal or hepatic), or death. Long-term effects can arise from metabolic disturbances or delayed treatment. Psychological sequelae, such as depression or anxiety, may also occur.

Lifestyle & Prevention

Prevention involves secure storage of medications, education on safe use, and addressing mental health needs. Support systems and crisis resources (e.g., hotlines) can help reduce self-harm risk. Regular follow-up with healthcare providers is recommended for those with a history of self-harm.

When to Seek Professional Help

Seek immediate medical attention if self-harm with insulin or oral hypoglycemics is suspected or confirmed. Signs of poisoning, such as altered mental status, seizures, or loss of consciousness, require urgent care. Psychiatric evaluation is critical to address intent and prevent recurrence.

Tips for Medical Coders

Document the intent (intentional self-harm) clearly in the medical record, as this distinguishes the code from accidental or therapeutic exposures. Ensure the code aligns with the clinical scenario and documentation. Verify that the code is used for initial encounters or subsequent care as appropriate.